Cite
Fashanu OE, Heckbert SR, Aguilar D, et al. Galectin-3 and Venous Thromboembolism Incidence: the Atherosclerosis Risk in Communities (ARIC) Study. Res Pract Thromb Haemost. 2017;1(2):223-230doi: 10.1002/rth2.12038.
Fashanu, O. E., Heckbert, S. R., Aguilar, D., Jensen, P. N., Ballantyne, C. M., Basu, S., Hoogeveen, R. C., deFilippi, C., Cushman, M., & Folsom, A. R. (2017). Galectin-3 and Venous Thromboembolism Incidence: the Atherosclerosis Risk in Communities (ARIC) Study. Research and practice in thrombosis and haemostasis, 1(2), 223-230. https://doi.org/10.1002/rth2.12038
Fashanu, Oluwaseun E, et al. "Galectin-3 and Venous Thromboembolism Incidence: the Atherosclerosis Risk in Communities (ARIC) Study." Research and practice in thrombosis and haemostasis vol. 1,2 (2017): 223-230. doi: https://doi.org/10.1002/rth2.12038
Fashanu OE, Heckbert SR, Aguilar D, Jensen PN, Ballantyne CM, Basu S, Hoogeveen RC, deFilippi C, Cushman M, Folsom AR. Galectin-3 and Venous Thromboembolism Incidence: the Atherosclerosis Risk in Communities (ARIC) Study. Res Pract Thromb Haemost. 2017 Oct;1(2):223-230. doi: 10.1002/rth2.12038. Epub 2017 Sep 04. PMID: 29152608; PMCID: PMC5685543.
Copy
Download .nbib